Microbio featured on Smart Company

Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)

Microbio closes latest investment round after surpassing $3.5m target

Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target

2022 Floods

Microbio sends its best wishes to all those affected by the floods in Queensland and New South Wales, including our own team members. Thank you (again!) to all the emergency workers for their extraordinary service to the community.

Microbio moves toward sovereign manufacturing of diagnostic tests

This is a Caption

Microbio has moved into new laboratories at Brisbane’s Translational Research Institute (TRI) with the aim of eventually setting up domestic manufacturing capability. More information can be found in the media release:211019_Microbio_moves_toward_sovereign_manufacturing_of_diagnostic_tests